Home » Stocks » DXR

Daxor Corporation (DXR)

Stock Price: $14.00 USD 0.12 (0.86%)
Updated November 23, 10:49 AM EST - Market open

Stock Price Chart

Key Info

Market Cap 54.44M
Revenue (ttm) 306,165
Net Income (ttm) -6.72M
Shares Out 3.89M
EPS (ttm) -1.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 23
Last Price $14.00
Previous Close $13.88
Change ($) 0.12
Change (%) 0.86%
Day's Open 14.00
Day's Range 14.00 - 14.25
Day's Volume 1,107
52-Week Range 7.85 - 24.08

More Stats

Market Cap 54.44M
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 3.89M
Float 946,391
EPS (basic) n/a
EPS (diluted) -1.15
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 13,683
Short Ratio 2.91
Short % of Float 1.45%
Beta -0.84
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 177.82
PB Ratio 4.99
Revenue 306,165
Operating Income n/a
Net Income -6.72M
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share n/a
Gross Margin 124.16%
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -0.43%
ROE -36.19%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

Current: $14.00
Target: 22.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name Daxor Corporation
Country United States
CEO Michael R. Feldschuh

Stock Information

Ticker Symbol DXR
Stock Exchange NYSE American
Sector Financial Services
Industry Asset Management
Unique Identifier NYSEAMERICAN: DXR


Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. Daxor Corporation has a cooperative research and development agreement with the Uniformed Services University of the Health Sciences for researching the effectiveness of BVA-100 diagnostic test on quantifying circulatory blood volume in the context of traumatic injury. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.